Trial Profile
Optimal options of antiviral programs in CKD combined with chronic hepatitis B immunosuppressive treatment patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2014 New trial record